GlassScriptPhysician profile
Lawrence G Hitzeman
NPI 1124248463
$82,242.75
in general payments reported to CMS, 2019-2025
13 companies · $10K in 2025
The $10K reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $11K · 2021: $5,465 · 2022: $13K · 2023: $10K · 2024: $11K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $26K · Travel and Lodging: $3,605 · Food and Beverage: $2,545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $25,750.00 |
| Travel and Lodging | $3,605.24 |
| Food and Beverage | $2,544.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $67,212.27 | 2019-2025 | Biktarvy |
| Viiv Healthcare Company | $13,966.28 | 2020-2023 | Dovato, Apretude |
| Janssen Products, LP | $335.95 | 2019-2022 | |
| Abbvie INC. | $145.00 | 2024 | |
| Novo Nordisk INC | $125.00 | 2022 | |
| Medtronic, INC. | $103.03 | 2022 | |
| Ethicon US, LLC | $103.02 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $100.61 | 2021-2023 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.50 | 2020 | |
| Merck Sharp & Dohme LLC | $16.80 | 2019 | |
| Mannkind Corporation | $14.45 | 2025 | |
| Theratechnologies INC. | $13.13 | 2024 | Trogarzo, Egrifta |
| Lilly USA, LLC | $11.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Hitzeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.